Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Liquidia Corp LQDA

Healthcare
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operates through its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LQDA)

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA(TM) (treprostinil) inhalation powder

GlobeNewswire April 1, 2024

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 13, 2024

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire March 6, 2024

Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

GlobeNewswire January 30, 2024

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA(TM) (treprostinil) inhalation powder

GlobeNewswire January 25, 2024

Liquidia Corporation Announces Updates to Operations Leadership

GlobeNewswire January 19, 2024

Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

GlobeNewswire January 8, 2024

Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

GlobeNewswire January 5, 2024
View More News ››

Opinion & Analysis (NDAQ:LQDA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LQDA)

Liquidia Corporation Provides Update on New Drug Application

Just In: $LQDA Liquidia Corporation Provides Update on New Drug Application for YUTREPIA(TM) (treprostinil) inhalation powderMORRISVILLE...
whytestocks - January 25, 2024

Peekaboo!!

Yeah yeah!!! 
MushLove - January 4, 2022
View more Bullboard ››

Silver Tiger Metals Inc

Silver Tiger Metals Inc

Silver Tiger Metals Inc. is a Canada-based company, which is engaged in exploring and developing the historic EL Tigre Mine ...
View More »